Defence Therapeutics Inc. | WebDisclosure

Basculer en Français

10109	Companies
207174	Keywords
137295	Articles
109800	Press releases

Headlines Articles Press releases Defence Therapeutics Inc.

Home
Companies
Defence Therapeutics Inc.

PRESS RELEASE

published on 06/17/2024 at 08:00, 1 year 9 months ago

DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin

Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF

published on 06/10/2024 at 08:05, 1 year 9 months ago

Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto

Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF

published on 06/10/2024 at 08:05, 1 year 9 months ago

Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto

Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE

published on 06/10/2024 at 08:00, 1 year 9 months ago

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment

Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF

published on 06/06/2024 at 08:05, 1 year 9 months ago

L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine

Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF

published on 06/06/2024 at 08:05, 1 year 9 months ago

Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine

Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE

published on 06/06/2024 at 08:00, 1 year 9 months ago

DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments

Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF

published on 05/14/2024 at 08:05, 1 year 10 months ago

Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale

Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF

published on 05/14/2024 at 08:05, 1 year 10 months ago

Defence Therapeutics Expands Patent Portfolio Globally

Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE

published on 05/14/2024 at 08:00, 1 year 10 months ago

DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals

Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology

Accesswire

Published on 03/29/2026 at 12:15, 5 hours 38 minutes ago

China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 1 day 15 hours ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 15 hours ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 day 16 hours ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 18 hours ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder

View all ACCESSWIRE

EQS Group

Published on 03/29/2026 at 17:05, 48 minutes ago

FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR
Published on 03/28/2026 at 10:05, 1 day 7 hours ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 8 hours ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 15 hours ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 18 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025

Les Echos

Published on 03/28/2026 at 07:00, 1 day 10 hours ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 1 day 21 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 1 day 21 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 22 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 day 22 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE